products medicine-distributors pfizer 
XTalks
MARCH 25, 2022
Pfizer has issued voluntary recalls for several lots of its blood pressure medication Accuretic, and two generic versions of it, over concerns of higher than acceptable levels of a nitrosamine called N-nitroso-quinapril, which is associated with an increased risk of cancer.
XTalks
NOVEMBER 30, 2023
Pfizer spinout SpringWorks Therapeutics’ Ogsiveo (nirogacestat) has received US Food and Drug Administration (FDA) approval for the treatment of desmoid tumors, an ultra-rare subtype of non-cancerous soft tissue sarcomas that can cause severe pain and disfigurement.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
SEPTEMBER 9, 2022
As a critical industry, any disruption to the production or distribution of pharmaceutical products can have significant cost implications for the industry and health ramifications for the global population”. Volatile weather conditions can interfere with this flow of products and create supply bottlenecks.”. Vulnerability .
Pharmaceutical Technology
MAY 15, 2023
Innovation S-curve for the pharmaceutical industry Peptide-based inhibitors are a key innovation area for cancer treatment Peptide-based inhibitors penetrate tumours/tissues and their chemical modifications and production facilitate improved stability and pharmacokinetics.
Pharmaceutical Technology
MAY 15, 2023
The company is engaged in the development and commercialisation of medicines for the treatment of cardiovascular, haematological and respiratory diseases, inflammation, liver diseases, and cancer. The company sells its products through subsidiaries and distributors in Europe, the Americas, Asia-Pacific, the Middle East, and Africa.
The Pharma Data
NOVEMBER 20, 2020
As Pfizer and BioNTech announced news of a possible Covid-19 vaccine on November 8 , in haste, pharma leaders are rallying to ensure supply chains will be able to support distribution. However, concerns from 500+ supply chain professionals reveals concerns about a lack of resilience as many prepare for third wave of Covid-19 infections.
The Pharma Data
DECEMBER 19, 2020
McKesson is not distributing the Pfizer ultra-frozen vaccine. The company has been the centralized distributor for the CDC’s Vaccines for Children program for 13 years, including during the H1N1 public health crisis. McKesson has a long history of managing the pharmaceutical and medical supply chain in the U.S.,
Expert insights. Personalized for you.
95 
Let's personalize your content